alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
WELLINGTON HALL, LIMITED AND SUBSIDIARIES

                   EXHIBIT 11 - EARNINGS PER SHARE COMPUTATION

<TABLE>
<CAPTION>
                                              2000             1999             1998
                                          ------------     ------------     ------------
Basic
<S>                                       <C>              <C>              <C>
   Weighted Average Shares Outstanding       3,781,553        2,315,458        2,289,887
                                          ============     ============     ============

   Net Loss                               $   (150,885)        (570,914)    $ (1,013,225)
                                          ============     ============     ============

   Per share amount                       $      (0.04)    $      (0.25)    $      (0.45)
                                          ============     ============     ============

Diluted
   Weighted Average Shares Outstanding       3,781,553        2.315.458        2,289,887
                                          ============     ============     ============

   Diluted potential common shares
     outstanding during the years                    0                0                0

   Total Shares                              3,781,553        2,315,458        2,289,887
                                          ============     ============     ============

   Net Loss                               $   (150,885)        (570,914)    $ (1,013,225)
                                          ============     ============     ============

   Per Share Amount                       $      (0.04)    $      (0.25)           (0.45)
                                          ============     ============     ============
</TABLE>
# laucnty96

&8Page &P of &N
```

                                                                      Exhibit 32

                           Section 1350 Certification

            Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
                   (Subsections (a) and (b) of Section 1350,
                  Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002 (subsections (a) and
(b) of Section 1350,  Chapter 63 of Title 18,  United States Code),  each of the
undersigned   officers  of  WHX   Corporation,   a  Delaware   corporation  (the
"Corporation"), does hereby certify that:

The Annual  Report on Form 10-K for the year ended  December 31, 2006 (the "Form
10-K") of the Corporation  fully complies with the requirements of Section 13(a)
or 15(d) of the  Securities  Exchange Act of 1934, as amended,  and  information
contained  in the Form 10-K  fairly  presents,  in all  material  respects,  the
financial condition and results of operations of the Corporation.

                                                     /s/ Glen M. Kassan
                                                     ---------------------------
                                                     Glen M. Kassan
                                                     Principal Executive Officer
May 18, 2007

                                                     /s/ Robert K. Hynes
                                                     ---------------------------
                                                     Robert K. Hynes
                                                     Principal Financial Officer
May 18, 2007
```
SERP II PARTICIPANT LISTING

Alexander, Mary              Active
Bacopulous, Dennis           Active
Bannister, Kim               Active
Beckner, Larry               Active
Contadino, Joe               Term - in payment
Eck, Robert                  Active
Gleason, Jack                Active
Haines, Chris                Active
Hanneman, LeRoy*             Active
Hennessy, G. Tom             Active
Higginson, Scott             Active
Hull, Ken                    Active
Jesberger, Michael           Active
Jones, Rob                   Active
Lucas, Tom                   Active
Mariucci, Anne               Active
McEnerny, Helen              Active
Mickus, Don                  Active
Murray, John                 Term - in payment
Newman, Gary                 Active
Noriega, Igor                Active
Pankratz, Frank              Active
Peterson, Scott              Active
Rau, David                   Active
Roach, Charles               Active
Ryan, Thomas                 Term - in payment
Schreiner, David             Active
Schuttenberg, Lynn           Active
Wagoner, Robert              Active
Widener, Scott               Active
Wilkins, Dennis              Term - in payment
[Federal Register Volume 74, Number 132 (Monday, July 13, 2009)]
[Notices]
[Pages 33475-33476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-16520]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in schedule I or II, and prior to issuing a 
regulation under 21 U.S.C. 952(a)(2) authorizing the importation of 
such a substance, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with Title 21, Code of Federal Regulations 
(CFR), 1301.34(a), this is notice that on June 16, 2009, Noramco, Inc., 
Division of Ortho-McNeil, Inc., 500 Swedes

[[Page 33476]]

Landing Road, Wilmington, Delaware 19801, made application by letter to 
the Drug Enforcement Administration (DEA) to be registered as an 
importer of Thebaine (9333), a basic class of controlled substance 
listed in schedule II.
    The company plans to import a Thebaine derivative for the bulk 
manufacture of controlled substances for their customers. The company 
will also import analytical reference standards for distribution to 
their customers for research purposes.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic class of controlled 
substance may file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43 and in 
such form as prescribed by 21 CFR 1316.47.
    Any such comments or objections being should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, VA 22152; and must be filed no later 
than August 12, 2009.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, 40 FR 43745-46), all applicants 
for registration to import a basic class of any controlled substances 
in schedule I or II are, and will continue to be, required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: July 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E9-16520 Filed 7-10-09; 8:45 am]
BILLING CODE 4410-09-P
<PAGE>

                                                                   EXHIBIT 32(B)

             SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER

     In connection with the Annual Report of New Valley Corporation (the
"Company") on Form 10-K for the period ended December 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, J.
Bryant Kirkland III, Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge:

          1. The Report fully complies with the requirements of Section 13(a) or
             15(d) of the Securities Exchange Act of 1934; and

          2. The information contained in the Report fairly presents, in all
             material respects, the financial condition and results of
             operations of the Company.

                                              /s/ J. BRYANT KIRKLAND III
                                          --------------------------------------
                                                  J. Bryant Kirkland III
                                            Vice President and Chief Financial
                                                         Officer

March 15, 2004
EXHIBIT 99.1



               VALENCE TECHNOLOGY COMPLETES $20 MILLION FINANCING

 FINANCING TO HELP FUEL THE COMPANY'S RECENTLY ANNOUNCED BUSINESS STRATEGY

--------------------------------------------------------------------------------

AUSTIN, TX, OCTOBER 9, 2001 --Valence Technology, Inc. (Nasdaq: VLNC), a leader
in the development and commercialization of Lithium-ion polymer rechargeable
batteries, today announced that it has secured $20 million in financing through
Berg & Berg Enterprises LLC, an affiliate of Carl Berg who is a director and
major shareholder of the Company.

Stephan B. Godevais, Valence president and chief executive officer, said, "In
August 2001, we set forth a detailed business strategy designed to establish
Valence as a leader in the energy solutions market. The completion of this
financing not only speaks to the strong support of our business strategy by Carl
Berg, but is also a critical step toward providing Valence with the financial
stability to successfully implement this strategy."

LOAN AGREEMENT DETAILS

Valence and Berg & Berg have entered into a loan agreement dated October 5,
2001. Under the terms of the agreement, Berg & Berg agrees to advance the
Company up to $20 million over the next two years, with all loans accruing
simple interest at 8% per annum and payable from time to time. All outstanding
loans under the agreement will be due and payable on September 30, 2005 and will
be secured by the assets of the Company. Advances under the agreement are
subject to customary conditions and will be used for working capital purposes.

ABOUT VALENCE TECHNOLOGY, INC.

Valence is a leader in the development and commercialization of Lithium-ion
polymer rechargeable batteries. Valence has more than 790 issued and pending
patents worldwide, including 284 issued in the U.S. Valence operates facilities
in Austin, Texas, Henderson, Nevada, and Mallusk, Northern Ireland. Valence is
traded on the Nasdaq National Market under the symbol VLNC. Valence can be found
on the Internet at www.valence.com.

FORWARD-LOOKING STATEMENTS

The information contained herein includes "forward-looking statements." The
company cautions readers not to put undue reliance on forward-looking
statements. Such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, and actual results may differ
materially from those described herein, for the reasons, among others, discussed
in our reports filed with the Securities and Exchange Commission.
#### UNITED STATES of America, Plaintiff-Appellee v. Bobby Glenn BANKS, Defendant-Appellant.

No. 12-2253.

United States Court of Appeals, Eighth Circuit.

Submitted: March 20, 2013.

Filed: April 11, 2013.

Jane W. Duke, Patrick C. Harris, Michael D. Johnson, Assistant U.S. Attorney, Edward O. Walker, U.S. Attorney’s Office, Little Rock, AR, for Plaintiff-Appellee.

Bobby Glenn Banks, Pollock, LA, pro se.

Before MURPHY, SMITH, and COLLOTON, Circuit Judges.

PER CURIAM.

Bobby Banks appeals the district court’s1 denial of his 18 U.S.C. § 3582(c)(2) motion to reduce his sentence under Amendment 750 of the United States Sentencing Guidelines. After careful review of the record, we conclude the district court did not abuse its discretion in finding that Banks was responsible for more than 2.8 kilograms of cocaine base, and thus that the amendment did not change his Guidelines range. *See United States v. Anderson,*707 F.3d 973, 974-75 (8th Cir.2013) (per curiam) (standard of review; district court may make new factual findings in considering § 3582(c)(2) motion, as long as they are consistent with original sentencing determination and supported by record). Accordingly, we affirm the judgment of the district court, grant counsel’s motion to withdraw, and deny Banks’s request for new counsel.

1

. The Honorable J. Leon Holmes, United States District Judge for the Eastern District of Arkansas.
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-END>                               DEC-31-1998
<CASH>                                       5,092,834
<INT-BEARING-DEPOSITS>                      13,765,064
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                 17,372,783
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                    284,313,294
<ALLOWANCE>                                  2,869,000
<TOTAL-ASSETS>                             336,194,991
<DEPOSITS>                                 201,930,962
<SHORT-TERM>                                38,384,275
<LIABILITIES-OTHER>                          5,836,232
<LONG-TERM>                                 63,844,266
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     2,755,076
<OTHER-SE>                                  23,444,180
<TOTAL-LIABILITIES-AND-EQUITY>             336,194,991
<INTEREST-LOAN>                             12,488,988
<INTEREST-INVEST>                              371,438
<INTEREST-OTHER>                               382,447
<INTEREST-TOTAL>                            13,242,873
<INTEREST-DEPOSIT>                           4,287,652
<INTEREST-EXPENSE>                           7,243,946
<INTEREST-INCOME-NET>                        5,998,927
<LOAN-LOSSES>                                  369,421
<SECURITIES-GAINS>                              58,490
<EXPENSE-OTHER>                              4,802,886
<INCOME-PRETAX>                              2,089,760
<INCOME-PRE-EXTRAORDINARY>                   2,089,760
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,336,605
<EPS-PRIMARY>                                     0.49
<EPS-DILUTED>                                     0.48
<YIELD-ACTUAL>                                   3.725
<LOANS-NON>                                  1,594,000
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                               184,896
<LOANS-PROBLEM>                                614,056
<ALLOWANCE-OPEN>                             2,978,000
<CHARGE-OFFS>                                  542,375
<RECOVERIES>                                    63,954
<ALLOWANCE-CLOSE>                            2,869,000
<ALLOWANCE-DOMESTIC>                            74,000
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                      2,795,000
        

</TABLE>
Advance copies of this statement are made available to the 

press under lock-up conditions with the explicit 

understanding that the data are embargoed until 8:30 a.m. 

Eastern Daylight Time. 

 

Statement of 

Lois Orr 

Acting Commissioner 

Bureau of Labor Statistics 

Friday, July 5, 2002 

 The unemployment rate was 5.9 percent and nonfarm 

payroll employment stood at 130.7 million in June, little 

changed from May. The labor market has been in a holding 

pattern in recent months, with nonfarm payroll employment 

essentially flat since February and no significant change 

in the unemployment rate since April. Although the number 

of unemployed has not changed significantly in the past 2 

months, long-term unemployment has continued to climb. 

 There were 8.4 million unemployed persons in June, 

about the same number as in the prior month, but 

approximately 2 million more than a year earlier. The 

unemployment rate, at 5.9 percent, was little changed over 

the month. Among the jobless, the number of persons 

unemployed for 15 weeks or more rose to 3.1 million, nearly 

double the number of such persons in June 2001. 
2

Nonfarm payroll employment was essentially unchanged 

in June (+36,000). Within the services division, health 

services added 34,000 jobs over the month, primarily in 

hospitals. Employment in help supply services was 

basically flat in June, following 3 consecutive monthly 

increases. Engineering and management services shed 21,000 

jobs, erasing the gains in this industry over the previous 

3 months. 

Manufacturing employment edged down by 23,000 in June, 

about in line with losses posted in the prior 2 months. 

Although employment in the industry continued to decline, 

losses have moderated in recent months. From the start of 

the recession (March 2001) through January 2002, the 

average monthly employment decline was 115,000. In 

February and March, losses averaged 63,000 per month; from 

April through June, they averaged 24,000 per month. The 

manufacturing workweek increased by two-tenths of an hour 

to 41.1 hours in June, the highest level since January 

2001. Factory overtime also increased over the month, 

edging up one-tenth of an hour to 4.3 hours. 

Average hourly earnings for production or 

nonsupervisory workers on private nonfarm payrolls were up 

by 6 cents over the month to $14.76. Over the year, 

average hourly earnings increased by 3.3 percent. 
3

In summary, data from both the establishment and 

household surveys showed little change in June, continuing 

the pattern of recent months. Although none of the major 

industry groups has shown substantial employment growth, 

the large job losses that characterized much of 2001 have 

abated.
IV 

108TH CONGRESS 

1ST SESSION H. RES. 284

Designating majority membership on certain standing committees of the 

House. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 19, 2003

Mr. TERRY submitted the following resolution; which was considered and 

agreed to 

RESOLUTION

Designating majority membership on certain standing 

committees of the House.

1 Resolved, That the following named Members be, and 

2 they are hereby, elected to the following standing commit3 tees of the House of Representatives: 

4 COMMITTEE ON AGRICULTURE: Mr. Neugebauer. 

5 COMMITTEE ON RESOURCES: Mr. Neugebauer. 

6 COMMITTEE ON SCIENCE: Mr. Neugebauer. 

7 COMMITTEE ON SMALL BUSINESS: Mr. McCotter.

Æ
Exhibit 99

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
No. 1262.

#### Feeley *v.*Ragen, Warden.

June 3, 1946.

Petition for writ of certiorari to the Criminal Court of Cook County, Illinois, denied.
### IN THE SUPREME COURT OF THE STATE OF MONTANA DA 23 - 0272

_________________ PLANNED PARENTHOOD OF MONTANA and PAUL FREDERICK HENKE, M.D., on behalf of themselves and their patients,

Plaintiffs and Appellees, v. ST ATE OF MON TA

NA and AUSTIN KNUDSEN, Attorney General of the State of Montana, in his official capacity, and his agents and successors,

Defendants and Appellants. O R D E R

_________________ Pursuant to the Unopposed Motion to Participate as Am ici Curiae f iled by American College of Obstetricians and Gynecologists, American Medical Association, Montana Medical Association, Society for Maternal - Fetal Medicine, and Society of Family Pla nning, and for good cause shown, IT IS HEREBY ORDERED that the motion is GRANTED. Amici are granted leave to file and serve their amicus brief on or before December 15, 2023 .

Electronically signed by: Beth Baker Justice, Montana Supreme Court December 11 2023

12/11/2023
Case Number: DA 23-0272
**SEC. File Nos.	**333-180729

	811-22692

** **

** **

 

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

 

 

**FORM N-1A**

Registration Statement

Under

the Securities Act of 1933

Post-Effective Amendment No. 3

and

Registration Statement

Under

the Investment Company Act of 1940

Amendment No. 5

 

 

 

**AMERICAN FUNDS COLLEGE TARGET DATE SERIES**

(Exact Name of Registrant as Specified in Charter)

 

6455 IrvineCenter Drive
Exhibit
32




Section
1350 Certification




Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002




(subsections
(a) and (b) of Section 1350, Chapter 63 of Title 18, United States
Code)




Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
Section 1350, Chapter 63 of Title 18, United States Code), each of the
undersigned officers of WHX Corporation, a Delaware corporation (the
“Corporation”), does hereby certify that:




The
Annual Report on Form 10-K for the year ended December 31, 2008 (the “Form
10-K”) of the Corporation fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934, as amended, and information
contained in the Form 10-K fairly presents, in all material respects, the
financial condition and results of operations of the Corporation.




/s/
      Glen
      M. KassanGlen
      M. KassanPrincipal
      Executive Officer


March 31,
2009







/s/
      James
      F. McCabe, Jr.James
      F. McCabe, Jr.Principal
      Financial Officer


March 31,
2009